Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 25883122.
- Also identified by DOI 10.2967/jnumed.115.158402 and PMC identifier 4587663.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Uniform Protocols for Imaging in Clinical Trials (UPICT) (18)F-FDG PET/CT protocol is intended to guide the performance of whole-body FDG PET/CT studies within the context of single- and multiple-center clinical trials of oncologic therapies by providing acceptable (minimum), target, and ideal standards for all phases of imaging. The aim is to minimize variability in intra- and intersubject, intra- and interplatform, interexamination, and interinstitutional primary or derived data. The goal of this condensed version of the much larger document is to make readers aware of the general content and subject area. The document has several main subjects: context of the imaging protocol within the clinical trial; site selection, qualification, and training; subject scheduling; subject preparation; imaging-related substance preparation and administration; imaging procedure; image postprocessing; image analysis; image interpretation; archiving and distribution of data; quality control; and imaging-associated risks and risk management.
Medical subject headings
- Fluorodeoxyglucose F18
- Multimodal Imaging
- Neoplasms
- Positron-Emission Tomography
- Tomography, X-Ray Computed